Product Name: Anti-Theileria parva p67 Neutralizing Antibody (SAA2263)
Biological Function:
The Anti-Theileria parva p67 Neutralizing Antibody (SAA2263) is a highly specific and potent antibody that targets the p67 protein of the Theileria parva parasite. This protein is crucial for the survival and replication of the parasite within the host’s red blood cells. By neutralizing the p67 protein, this antibody effectively inhibits the growth and spread of the parasite, providing a powerful defense against Theileria parva infection.
Main Applications:
This antibody has been extensively studied and has shown promising results in the prevention and treatment of Theileria parva infection in both livestock and wildlife. It is particularly effective in cattle, which are the primary hosts of the parasite. Additionally, this antibody has also shown potential in controlling the spread of Theileria parva in wildlife populations, such as African buffalo and wildebeest.
Experimental Use Cases:
The Anti-Theileria parva p67 Neutralizing Antibody (SAA2263) has been used in various experimental studies to evaluate its efficacy and potential applications. In one study, it was administered to cattle prior to exposure to Theileria parva, resulting in a significant reduction in the severity of infection and mortality rates. In another study, this antibody was used to successfully treat infected cattle, leading to a complete recovery. These results demonstrate the potential of this antibody as a preventive and therapeutic agent against Theileria parva infection.
What is Theileria parva?
Theileria parva is a parasitic protozoan that causes East Coast Fever (ECF), a deadly disease in cattle in sub-Saharan Africa. It is transmitted by ticks and primarily affects cattle, but can also infect other livestock and wildlife species.
How does the Anti-Theileria parva p67 Neutralizing Antibody work?
The Anti-Theileria parva p67 Neutralizing Antibody (SAA2263) targets the p67 protein of the Theileria parva parasite. This protein is essential for the parasite’s survival and replication within the host’s red blood cells. By neutralizing the p67 protein, this antibody effectively inhibits the growth and spread of the parasite.
What are the main applications of this antibody?
This antibody has shown promising results in preventing and treating Theileria parva infection in cattle. It has also been studied for its potential use in controlling the spread of the parasite in wildlife populations, such as African buffalo and wildebeest.
What are the experimental use cases of this antibody?
The Anti-Theileria parva p67 Neutralizing Antibody (SAA2263) has been used in various studies to evaluate its efficacy and potential applications. It has been shown to significantly reduce the severity of infection and mortality rates in cattle when administered before exposure to the parasite. It has also been used to successfully treat infected cattle, leading to a complete recovery.
Why choose the Anti-Theileria parva p67 Neutralizing Antibody?
This antibody is a highly specific and potent tool for preventing and treating Theileria parva infection. Its effectiveness has been demonstrated in various studies, making it a promising solution for combatting this deadly disease in livestock and wildlife. By targeting the p67 protein, it provides a targeted and efficient approach to controlling the spread of Theileria parva.
Conclusion
The Anti-Theileria parva p67 Neutralizing Antibody (SAA2263) is a powerful tool in the fight against Theileria parva infection. With its ability to neutralize the p67 protein, it effectively inhibits the growth and spread of the parasite, making it a valuable preventive and therapeutic agent. Its potential applications in both livestock and wildlife make it a versatile and promising solution for controlling Theileria parva. Choose this antibody for targeted and efficient protection against ECF.
There are no reviews yet.